R2TMC Public Health Unit

20/01/2026

Ngayong buwan ng Enero, ating ipinagdiriwang ang mga sumusunod na 𝐃𝐎𝐇 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐨𝐧𝐬:

𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐃𝐞𝐰𝐨𝐫𝐦𝐢𝐧𝐠 𝐌𝐨𝐧𝐭𝐡
𝐒𝐜𝐡𝐢𝐬𝐭𝐨𝐬𝐨𝐦𝐢𝐚𝐬𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐚𝐧𝐝 𝐌𝐚𝐬𝐬 𝐃𝐫𝐮𝐠 𝐀𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐌𝐨𝐧𝐭𝐡
𝐋𝐢𝐯𝐞𝐫 𝐂𝐚𝐧𝐜𝐞𝐫 𝐚𝐭 𝐇𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐌𝐨𝐧𝐭𝐡
𝐀𝐮𝐭𝐢𝐬𝐦 𝐂𝐨𝐧𝐬𝐜𝐢𝐨𝐮𝐬𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤
𝐆𝐨𝐢𝐭𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤
𝐖𝐨𝐫𝐥𝐝 𝐍𝐞𝐠𝐥𝐞𝐜𝐭𝐞𝐝 𝐓𝐫𝐨𝐩𝐢𝐜𝐚𝐥 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐚𝐲
𝐖𝐨𝐫𝐥𝐝 𝐋𝐞𝐩𝐫𝐨𝐬𝐲 𝐃𝐚𝐲

Itaguyod ang ating kaalaman tungkol sa kalusugan para sa healthy na isipan at katawan dahil 𝑺𝒂 𝑩𝒂𝒈𝒐𝒏𝒈 𝑷𝒊𝒍𝒊𝒑𝒊𝒏𝒂𝒔, 𝑩𝒂𝒘𝒂𝒕 𝑩𝒖𝒉𝒂𝒚 𝑴𝒂𝒉𝒂𝒍𝒂𝒈𝒂.

16/01/2026

𝟑𝐫𝐝 𝐖𝐞𝐞𝐤 𝐨𝐟 𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝐢𝐬 𝐀𝐮𝐭𝐢𝐬𝐦 𝐂𝐨𝐧𝐬𝐜𝐢𝐨𝐮𝐬𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤! 🧩
🤝 Magkaisa tayo sa pagpapalaganap ng kamalayan at pagtanggap. Ipakita ang pagmamalasakit at respeto para sa mga may autism at kanilang mga pamilya. 🌟💖
Ano ang maaari mong gawin?
✅ Dumalo sa mga forum, seminar, at workshop tungkol sa autism.
✅ Magbahagi ng tamang impormasyon sa inyong mga kaibigan at pamilya.
✅ Suportahan ang mga inisyatibo at organisasyong tumutulong sa autism community.
✅ Gamitin ang social media upang ipahayag ang iyong suporta gamit ang hashtag: 📲
Tayo na’t magkaisa para sa isang inklusibong lipunan! 💙 Dahil sa Bagong Pilipinas, bawat buhay mahalaga! 🌏✨
Isulong ang lipunang walang naiiwan

𝟑𝐫𝐝 𝐖𝐞𝐞𝐤 𝐨𝐟 𝐉𝐚𝐧𝐮𝐚𝐫𝐲 𝐢𝐬 𝐀𝐮𝐭𝐢𝐬𝐦 𝐂𝐨𝐧𝐬𝐜𝐢𝐨𝐮𝐬𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤! 🧩

🤝 Magkaisa tayo sa pagpapalaganap ng kamalayan at pagtanggap. Ipakita ang pagmamalasakit at respeto para sa mga may autism at kanilang mga pamilya. 🌟💖

Ano ang maaari mong gawin?
✅ Dumalo sa mga forum, seminar, at workshop tungkol sa autism.
✅ Magbahagi ng tamang impormasyon sa inyong mga kaibigan at pamilya.
✅ Suportahan ang mga inisyatibo at organisasyong tumutulong sa autism community.
✅ Gamitin ang social media upang ipahayag ang iyong suporta gamit ang hashtag: 📲

Tayo na’t magkaisa para sa isang inklusibong lipunan! 💙 Dahil sa Bagong Pilipinas, bawat buhay mahalaga! 🌏✨

Isulong ang lipunang walang naiiwan

13/01/2026

𝐅𝐃𝐀 𝐒𝐓𝐀𝐓𝐄𝐌𝐄𝐍𝐓 𝐎𝐍 𝐓𝐇𝐄 𝐕𝐎𝐋𝐔𝐍𝐓𝐀𝐑𝐘 𝐑𝐄𝐂𝐀𝐋𝐋 𝐎𝐅 𝐒𝐄𝐋𝐄𝐂𝐓 𝐈𝐍𝐅𝐀𝐍𝐓 𝐅𝐎𝐑𝐌𝐔𝐋𝐀 𝐏𝐑𝐎𝐃𝐔𝐂𝐓𝐒
The Food and Drug Administration (FDA) informs the public that it is actively overseeing and validating the voluntary recall initiated by Nestlé Philippines involving specific batches of NAN OPTIPRO and NANKID OPTIPRO infant formula products as a precautionary measure following the identification of a potential safety and quality concern.
The voluntary recall follows a reported incident involving a raw material from the manufacturer’s supplier. At present, there are no established food safety or regulatory limits on the raw material identified. The FDA is conducting an ongoing investigation to determine the scope of the issue and to assess any potential safety implications.
In close coordination with the manufacturer, the FDA is verifying the specific affected batches, ensuring the prompt and complete removal of recalled products from physical and online retail outlets, and conducting distribution and communication checks to confirm that recall measures are effectively implemented across the supply chain.
At this time, the FDA has not received any reports of illness or adverse events associated with the recalled products. While no adverse events have been reported, the FDA fully supports this precautionary action to protect public health, especially infants and young children.
The FDA advises consumers to carefully check product batch numbers, immediately discontinue use of any affected products, and strictly follow the recall instructions issued by the manufacturer. An official FDA Advisory for the guidance of the general public will be issued to provide further information and updates.
The FDA will continue to carry out post-market surveillance, inspections, and product assessments to ensure that all regulated products in the market meet established safety and quality requirements. Any significant findings will be promptly disclosed in the interest of transparency and consumer protection.
The FDA remains steadfast in fulfilling its mandate to protect public health and to ensure that all regulated health products available to consumers are safe, of good quality, and compliant with applicable laws and regulations.

𝐅𝐃𝐀 𝐒𝐓𝐀𝐓𝐄𝐌𝐄𝐍𝐓 𝐎𝐍 𝐓𝐇𝐄 𝐕𝐎𝐋𝐔𝐍𝐓𝐀𝐑𝐘 𝐑𝐄𝐂𝐀𝐋𝐋 𝐎𝐅 𝐒𝐄𝐋𝐄𝐂𝐓 𝐈𝐍𝐅𝐀𝐍𝐓 𝐅𝐎𝐑𝐌𝐔𝐋𝐀 𝐏𝐑𝐎𝐃𝐔𝐂𝐓𝐒

The Food and Drug Administration (FDA) informs the public that it is actively overseeing and validating the voluntary recall initiated by Nestlé Philippines involving specific batches of NAN OPTIPRO and NANKID OPTIPRO infant formula products as a precautionary measure following the identification of a potential safety and quality concern.

The voluntary recall follows a reported incident involving a raw material from the manufacturer’s supplier. At present, there are no established food safety or regulatory limits on the raw material identified. The FDA is conducting an ongoing investigation to determine the scope of the issue and to assess any potential safety implications.

In close coordination with the manufacturer, the FDA is verifying the specific affected batches, ensuring the prompt and complete removal of recalled products from physical and online retail outlets, and conducting distribution and communication checks to confirm that recall measures are effectively implemented across the supply chain.

At this time, the FDA has not received any reports of illness or adverse events associated with the recalled products. While no adverse events have been reported, the FDA fully supports this precautionary action to protect public health, especially infants and young children.

The FDA advises consumers to carefully check product batch numbers, immediately discontinue use of any affected products, and strictly follow the recall instructions issued by the manufacturer. An official FDA Advisory for the guidance of the general public will be issued to provide further information and updates.

The FDA will continue to carry out post-market surveillance, inspections, and product assessments to ensure that all regulated products in the market meet established safety and quality requirements. Any significant findings will be promptly disclosed in the interest of transparency and consumer protection.

The FDA remains steadfast in fulfilling its mandate to protect public health and to ensure that all regulated health products available to consumers are safe, of good quality, and compliant with applicable laws and regulations.

08/01/2026

‼️DOH, NAGMUNGKAHI NG 12 HEALTHY HABITS NGAYONG 2026‼️
Narito ang labindalawang healthy habits mula sa Department of Health para sa mas PinaSiglang 2026.
Balikan ang PinaSigla Episode 23 dito:
📌 https://web.facebook.com/share/p/175zKcVUzb/
📌https://www.youtube.com/watch?v=hDdPNIP9deU...

‼️DOH, NAGMUNGKAHI NG 12 HEALTHY HABITS NGAYONG 2026‼️

Narito ang labindalawang healthy habits mula sa Department of Health para sa mas PinaSiglang 2026.

Balikan ang PinaSigla Episode 23 dito:

📌 https://web.facebook.com/share/p/175zKcVUzb/

📌https://www.youtube.com/watch?v=hDdPNIP9deU&list=PL7amYNiWriCysYdFXyyXQdFeXvmWtBaGz&index=1

23/12/2025

‼️ DOH: NANAWAGANG MAGING SENSITIBO AT MAPAG-UNAWA SA PINAGDADAANAN NG IBA NGAYONG PASKO‼️
Bukod sa non-communicable disease, partikular sa sakit sa puso, tuloy-tuloy din ang serbisyo ng DOH para umagapay sa mga mangangailangan ng mental health support.
Paalala ni Sec. Ted Herbosa, maging mas sensitibo at maingat sa nararamdaman ng kapwa, lalo na ngayong Pasko at Bagong Taon. Maging bukas sa pakikinig sa kaanak o kaibigan na may pinagdadaanan.
Para sa National Center for Mental Health Help Line, maaaring tumawag sa mga sumusunod na numero:
☎️1553
📱0919-057-1553
📱0917-899-8727

22/12/2025

R2TMC Participates in NIA GAD Seminar on Health and Wellness

Region II Trauma and Medical Center (R2TMC) actively participated in the National Irrigation Administration (NIA) Gender and Development (GAD) Seminar on Health and Wellness Program. The activity was held at the National Irrigation Administration-Nueva
Vizcaya Irrigation Management Office (NIA-NVIMO) Covered Court, Capitol Compound, Bayombong, Nueva Vizcaya on December 19, 2025.

The program was organized by the NIA-NVIMO, led by Ms. Felipa S. Sumer, Division Manager A, with the assistance of Ms. Pelita Marie C. Gabriel, Engineer A/GAD FPS Member and Mr. Ceferino M. Florentin IV, Acting Admin Services Officer A/GAD FPS member, in partnership with the Bayombong Solano Villaverde Federation of Irrigator’s Association (BSFVIA). This initiative forms part of the continuing commitment of the NIA-NVIMO to promote gender equality, inclusivity, and holistic well-being. Participants included NIA-NVIMO staff and representatives from BSFVIA.

It was conducted in coordination with the R2TMC Public Health Unit (PHU) head, Dr. Jenny B. San Pedro, and Health Education and Promotion Officer III, Mr. George B. Basilio. Accordingly, R2TMC was represented by personnel from the PHU, Integrated Delivery of Tuberculosis Services (iDOTs) facility, Obstetrics and Gynecology Department, Family Medicine Department, Psychology Unit, and Talinaay Center.

Highlights of the program were the comprehensive health lectures designed to promote awareness, prevention and early intervention. Key topics included Hepatitis, discussed by Dr. Dominador D. Wayet, Jr.; Mental Wellness, presented by Ms. Roilyn C. Duro; Reproductive Health, led by Dr. Jane L. Publico; Human Immunodeficiency Virus (HIV), explained by Mr. Guillermo B. Francisco; and Tuberculosis (TB), presented by Dr. Edel Grace Lasam. In addition to the key topics, R2TMC services were also promoted during the activity. PHU staff, Ms. Ialaina Elaine A. Manalo and Mr. Nathan Jay A. Cariazo introduced participants to the official social media platforms of the hospital and the General Medicine online appointment system, highlighting accessible and convenient healthcare services.

An interactive open forum followed the lectures, allowing participants to raise questions and seek clarifications not only on the discussed topics but also on other health-related concerns and available services. The engagement underscored the importance of health promotion within the community.

R2TMC extends its sincere appreciation to NIA-NVIMO and the BSVFSIA for the opportunity to participate in and contribute to their Gender and Development initiative featuring the promotion of health.

17/12/2025

17/12/2025

Everything you need to know about UNIVERSAL HEALTH CARE (UHC)

16/12/2025

ABANGAN BUKAS!

13/12/2025

Ilang tulog na lamang ay Pasko na!🎄
Gawing 𝑳𝒊𝒈𝒕𝒂𝒔 𝑪𝒉𝒓𝒊𝒔𝒕𝒎𝒂𝒔 ang Holiday ng Pamilya!👨‍👩‍👧

✔𝐈𝐬𝐚𝐛𝐮𝐡𝐚𝐲 𝐚𝐧𝐠 𝐓.𝐄.𝐃.
✔𝐒𝐢𝐠𝐮𝐫𝐚𝐝𝐮𝐡𝐢𝐧𝐠 𝐁𝐢𝐲𝐚𝐇𝐞𝐚𝐥𝐭𝐡𝐲 𝐚𝐭
❌𝐔𝐦𝐢𝐰𝐚𝐬 𝐬𝐚 𝐩𝐚𝐩𝐮𝐭𝐨𝐤

Sundin ang 𝑳𝒊𝒈𝒕𝒂𝒔 𝑪𝒉𝒓𝒊𝒔𝒕𝒎𝒂𝒔 tips upang kompleto at ligtas ang buong pamilya, sapagkat 𝒮𝒶 𝐵𝒶𝑔𝑜𝓃𝑔 𝒫𝒾𝓁𝒾𝓅𝒾𝓃𝒶𝓈, 𝐵𝒶𝓌𝒶𝓉 𝐵𝓊𝒽𝒶𝓎 𝑀𝒶𝒽𝒶𝓁𝒶𝑔𝒶.

04/12/2025

‼️DOH: Maging mapanuri sa mga gamot at bakuna na binebenta online o ng hindi awtorisadong pasilidad‼️
Dahil sa pagdami ng mga binebentang pekeng gamot at iba pang produktong medikal sa merkado, nagpaalala ang DOH na maging mapanuri at huwag bilhin kung:
❌May mali sa label o spelling at kakaiba ang itsura ng packaging
❌Kulang ang FDA batch/ lot number, manufacturing at expiration date
❌Kakaiba ang itsura ng gamot tulad ng hugis, amoy, o lasa
❌Walang bisa
❌Walang lisensya ang seller o ang pasilidad para magbenta
I-report agad sa FDA kung may mapansing kahina-hinalang gamot o bakuna: ereport@fda.gov.ph o (02) 8809-5596.

‼️DOH: Maging mapanuri sa mga gamot at bakuna na binebenta online o ng hindi awtorisadong pasilidad‼️

Dahil sa pagdami ng mga binebentang pekeng gamot at iba pang produktong medikal sa merkado, nagpaalala ang DOH na maging mapanuri at huwag bilhin kung:

❌May mali sa label o spelling at kakaiba ang itsura ng packaging
❌Kulang ang FDA batch/ lot number, manufacturing at expiration date
❌Kakaiba ang itsura ng gamot tulad ng hugis, amoy, o lasa
❌Walang bisa
❌Walang lisensya ang seller o ang pasilidad para magbenta

I-report agad sa FDA kung may mapansing kahina-hinalang gamot o bakuna: ereport@fda.gov.ph o (02) 8809-5596.